History and Development of International SHR Symposia

  Year  Chairman  Venue  Title 
1st  1971  K. Okamoto   Kyoto, Japan  SHR/ Pathogenesis and Complications
2nd  1976  E. Freis / M. Bumpus    Newport Beach, USA  SHR/ Pathogenesis and Complications
3rd  1978  K. Okamoto   Kyoto, Japan  Spontaneous Hypertension and Related Studies
4th  1981  F. Gross / D. Ganten
 Honor. K. Okamoto 
 Heidelberg, Germany  SHR and Related Studies
5th  1985  Y.Yamori
 Hor. K. Okamoto 
 Kyoto, Japan  Contribution of SHR to Medicine
6th  1989  M. Brody 
 Hor. K. Okamoto 
 Iowa, USA  SHR and Related Studies
7th  1991  J.Sassard
 Hor. K. Okamoto
 Lyon,  France   SHR and Related Studies
8th  1994  A. Suzuki
 Hor. K. Okamoto & M. Seko 
 Osaka, Japan  SHR and Cardiovascular Genetics
9th  1997  P. Hamet    Montreal, Canada  SHR and Cardiovascular Genetics
10th  2001  D. Ganten   Berlin,  Germany   SHR and Molecular Medicine
11th  2004  D. McCarron / Y. Yamori    Portland,  USA   SHR and Cardiovascular Risk
12th  2006  I. Nishio / Y. Yamori    Kyoto, Japan  (Satellite to ISH Fukuoka)
 SHR / Genetics of Experimental and Human Hypertension in
 Relation with Environmental Factors
13th  2008  J. Kunes / J. Zicha   Prague, 
 Czech  Republic 
 (Satellite to ISH Berlin) 
 SHR / Etiology of Genetic Hypertension and Metabolic Syndrome
14th  2010  P. Hamet  Montreal,  Canada    Ecogenomic Models of Cardiometabolic Diseases
15th  2012  S. Harrap  Melbourne,  Australia  (Satellite to ISH Sydney) 
 Cardiovascular Genetics incorporating the 15th International
SHR Symposium & 48th Japanese SHR Meeting
16th 2014  M. Volpe / S. Rubattu  Rome, Italy  (Satellite to ISH Athens) 
  Genetic basis of hypertension 
17th 2016  M. Soma  Tokyo, Japan  (Satellite to ISH Seoul) 
 Forefront of Cardiovascular Genetics Research
18th 2018  Pingjin GAO  Shanghai, China (Satellite to ISH Beijing) 
Inflammation, immunity and genetics in hypertension in both humans and model animals  
19th 2021  A.F. Dominiczak  Glasgow, UK (Satellite to ISH Glasgow)
Genetics and disease model guided novel therapeutic target discovery in hypertension
20th 2022  N.Kato  Kyoto, Japan (Satellite to ISH Kyoto)
Innovative science of hypertension-related disease model towards precision medicine and prevention